Abstract
Non-melanoma skin cancer (NMSC) is the most common form of skin cancer and often affects the frequently sun-exposed areas of the head and neck. In 2008, an estimated 430,000 new cases were diagnosed in Australia [1]. Two-thirds of Australians over the age of 70 years will develop a NMSC, most of which are basal cell carcinomas (BCCs) that rarely metastasize to lymph nodes. The occurrence of squamous cell carcinomas (SCCs) is approximately half that of BCCs but their capacity for lymph node metastases is much greater [2]. Merkel cell carcinoma (MCC) is a rare but aggressive cutaneous neuroendocrine tumour that has a high propensity for regional and distant spread.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cancer Australia and AIHW. Non-melanoma skin cancer: general practice consultations, hospitalisation and mortality. Cat. no. CAN 39. Canberra: AIHW; 2008.
Buettner P, Raasch B. Incidence rates of skin cancer in townsville, Australia. Int J Cancer. 1998;78:587–93.
Joseph MG, Zulueta WP, Kennedy PJ. Squamous cell carcinoma of the skin of the trunk and limbs: the incidence of metastases and their outcome. Aust N Z J Surg. 1992;62:697–701.
Veness MJ, Palme CE, Morgan GJ. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer. 2006;106:2389–96.
Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307–17.
Valsecchi ME, Silbermins D, de Rosa N, et al. Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis. J Clin Oncol. 2011;29:1479–87.
Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927–33.
Kowalski LP, Sanabria A. Elective neck dissection in oral carcinoma: a critical review of the evidence. Acta Otorhinolaryngol Ital. 2007;27:113–7.
Jol AD, van Velthuysen ML, Hilgers FJ, et al. Treatment results of regional metastasis from cutaneous head and neck squamous cell carcinoma. Eur J Surg Oncol. 2003;29:81–6.
Oddone N, Morgan GJ, Palme CE, et al. Metastatic cutaneous squamous cell carcinoma of the head and neck: the immunosuppression, treatment, extranodal spread, and margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Cancer. 2009;115:1883–91.
Gore SM, Shaw D, Martin RCW, et al. Prospective study of sentinel node biopsy for high risk cutaneous squamous cell carcinoma of the head and neck. Head and Neck. 2015 [ahead of print] doi: 10.1002/hed.24120
O’Brien CJ, McNeil EB, McMahon JD, et al. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. Head Neck. 2002;24:417–22.
Andruchow JL, Veness MJ, Morgan GJ, et al. Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes. Cancer. 2006;106:1078–83.
Erman AB, Collar RM, Griffith KA, et al. Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma. Cancer. 2012;118:1040–7.
Civantos FJ, Moffat FL, Goodwin WJ. Lymphatic mapping and sentinel lymphadenectomy for 106 head and neck lesions: contrasts between oral cavity and cutaneous malignancy. Laryngoscope. 2006;112 Suppl 109:1–15.
Altinyollar H, Berberoglu U, Celen O. Lymphatic mapping and sentinel lymph node biopsy in squamous cell carcinoma of the lower lip. Eur J Surg Oncol. 2002;28:72–4.
Reschly MJ, Messina JL, Zaulyanov LL, et al. Utility of sentinel lymphadenectomy in the management of patients with high-risk cutaneous squamous cell carcinoma. Dermatol Surg. 2003;29:135–40.
Michl C, Starz H, Bachter D. Sentinel lymphonodectomy in nonmelanoma skin malignancies. Br J Dermatol. 2003;149:763–9.
Nouri KR, Pedroso F, Bhatia R, et al. Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma of the head and neck. Arch Dermatol. 2004;140:1284.
Wagner JD, Evdokimow DZ, Weisberger E, et al. Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch Dermatol. 2004;140:75–9.
Civantos Jr F, Zitsch R, Bared A, et al. Sentinel node biopsy for squamous cell carcinoma of the head and neck. J Surg Oncol. 2008;97:683–90.
Renzi C, Caggiati A, Mannooranparampil TJ, et al. Sentinel lymph node biopsy for high risk cutaneous squamous cell carcinoma: case series and review of the literature. Eur J Surg Oncol. 2007;33:364–9.
Rastrelli M, Soteldo J, Zonta M, et al. Sentinel node biopsy for high-risk cutaneous nonanogenital squamous cell carcinoma: a preliminary result. Eur Surg Res. 2010;44:204–8.
D’Souza J, Clark J. Management of the neck in metastatic cutaneous squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg. 2011;19:99–105.
Lo JS, Snow SN, Reizner GT, et al. Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. J Am Acad Dermatol. 1991;24:715–9.
Cracchiolo JR, Liu JC. Lymphadenectomy for anterior cutaneous malignancies of the head and neck. Oper Tech Otolaryngol Head Neck Surg. 2013;24:19–23.
Harwood M, Wu H, Tanabe K, et al. Metastatic basal cell carcinoma diagnosed by sentinel lymph node biopsy. J Am Acad Dermatol. 2005;53:475–8.
Ducic Y, Marra DE. Metastatic basal cell carcinoma. Am J Otolaryngol. 2011;32:455–8.
Eng TY, Boersma MG, Fuller CD, et al. A comprehensive review of the treatment of Merkel cell carcinoma. Am J Clin Oncol. 2007;30:624–36.
Gupta SG, Wang LC, Peñas PF, et al. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the dana-farber experience and meta-analysis of the literature. Arch Dermatol. 2006;142:685–90.
Lemos BD, Storer BE, Iyer JG, et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol. 2010;63:751–61.
Fields RC, Busam KJ, Chou JF, et al. Recurrence and survival in patients undergoing sentinel lymph node biopsy for Merkel cell carcinoma: analysis of 153 patients from a single institution. Ann Surg Oncol. 2011;18:2529–37.
Maza S, Trefzer U, Hofmann M, et al. Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literature. Eur J Nucl Med Mol Imaging. 2006;33:433–40.
Kouzmina M, Leikola J, Böhling T, et al. Positive sentinel lymph node biopsy predicts local metastases during the course of disease in Merkel cell carcinoma. J Plast Surg Hand Surg. 2013;47:139–43.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Faruque Riffat, Carsten E. Palme, Michael Veness, Rehan Kazi, Raghav C. Dwivedi
About this chapter
Cite this chapter
Wykes, J., Clark, J., Niles, N. (2015). The Role of Sentinel Lymph Node Biopsy in Non-melanoma Skin Cancer of the Head and Neck. In: Riffat, F., Palme, C., Veness, M. (eds) Non-melanoma Skin Cancer of the Head and Neck. Head and Neck Cancer Clinics. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2497-6_7
Download citation
DOI: https://doi.org/10.1007/978-81-322-2497-6_7
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-2496-9
Online ISBN: 978-81-322-2497-6
eBook Packages: MedicineMedicine (R0)